Vera F Dolan
Overview
Explore the profile of Vera F Dolan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
53
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dolan V
J Insur Med
. 2025 Mar;
52(1):23-30.
PMID: 40047112
Patients addicted to prescription opiates have found innovative ways to reliably obtain their desired prescription opiates at a time when such prescriptions are restricted due to the opioid crisis. Instead...
2.
Dolan V
J Insur Med
. 2024 Sep;
51(2):51-54.
PMID: 39265997
Fetal alcohol spectrum disorder (FASD) and its associated physical and mental conditions is the most prevalent congenital impairment causing developmental and intellectual disability worldwide. Like alcohol abuse, FASD is typically...
3.
Dolan V
J Insur Med
. 2024 Sep;
51(3):193-198.
PMID: 39260451
Moral hazard is well known to life insurance underwriters and medical directors to increase the risk of adverse consequences to insured individuals. The underwriting investigation of proposed insureds at time...
4.
Dolan V
J Insur Med
. 2023 Feb;
49(4):250-253.
PMID: 36757271
Detecting undisclosed methamphetamine and heroin abuse is a challenge for life underwriters and medical directors. A common clinical assumption is that if substance abusers experience liver damage, it will be...
5.
Fulks M, Dolan V, Stout R
J Insur Med
. 2016 Sep;
45(2):75-80.
PMID: 27584842
Objective .- Determine if the addition of hemoglobin testing improves risk prediction for life insurance applicants. Method .- Hemoglobin results for insurance applicants tested from 1993 to 2007, with vital...
6.
Fulks M, Stout R, Dolan V
J Insur Med
. 2016 Sep;
45(1):28-33.
PMID: 27584806
Objective .- Redefine the "normal" reference range for blood pressure from <140/90 to one that more effectively identifies individuals with increased mortality risk. Method .- Data from the recently published...
7.
Fulks M, Dolan V, Stout R
J Insur Med
. 2016 Sep;
45(1):17-27.
PMID: 27584805
Objective .- Define the relative mortality risk by systolic (SBP) and diastolic blood pressure (DBP) in a relatively healthy cohort split by age and sex with adjustment for smoking status,...
8.
Fulks M, Dolan V, Stout R
J Insur Med
. 2016 Aug;
46(1):13-9.
PMID: 27562108
Objective .- Determine the impact of build on insurance applicant mortality accounting for smoking, laboratory test values and blood pressure. Method .- The study consisted of 2,051,370 applicants tested at...
9.
Fulks M, Stout R, Dolan V
J Insur Med
. 2015 Mar;
44(2):93-8.
PMID: 25816467
Objective: Determine the relative mortality in apparently healthy adults with various levels of serum globulin. Method: By use of the Social Security Death Master File, mortality in 2010 was determined...
10.
Clark M, Kaufman V, Fulks M, Dolan V, Stout R
J Insur Med
. 2014 Jul;
44(1):7-16.
PMID: 25004594
Objective: Quantify the independent value of NT-proBNP in predicting all-cause mortality for individual life insurance applicants and establish risk-based reference ranges. Method: By use of the Social Security Death Master...